LITE: Long-term Lifestyle Change and Testosterone Replacement
Study Details
Study Description
Brief Summary
Older hypogonadal obese veterans previously participated in a 6 month lifestyle change (diet-induced weight loss and exercise) study with or without testosterone replacement therapy before being followed for the following year at the clinic while receiving standard of care consisting of diet and exercise counseling (for healthy lifestyle change) and testosterone replacement therapy. This study will determine if long-term lifestyle change and testosterone replacement therapy with associated improvement in physical and metabolic health can be maintained in obese older adults.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Detailed Description
Background: There are studies on long-term testosterone replacement in older adults with hypogonadism showing benefits on body composition, sexual function and mood but not on testosterone replacement therapy in combination with lifestyle change (diet-induced weight loss and exercise) in the specific population of older adults with both obesity and hypogonadism.
Purpose: To determine if long-term lifestyle change and testosterone replacement therapy with associated improvement in physical and metabolic health can be maintained in obese older adults .
Design: Overweight/obese older veteran patients with obesity and hypogonadism who are being followed at the endocrine clinic while receiving standard of care consisting of diet and exercise counseling (for healthy lifestyle change) and testosterone replacement therapy will be recruited for testing of physical, metabolic, cognitive/mood, quality of life, and body composition testing.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| testosterone, diet, and increased physical activity Group receiving standard of care consisting of diet and regular exercise counseling + testosterone replacement therapy |
Drug: Testosterone replacement
Testosterone replacement therapy
Behavioral: lifestyle
lifestyle intervention consisting of diet and increased physical activity
|
Outcome Measures
Primary Outcome Measures
- Change in Physical Performance Test score [18 month]
The primary functional outcome is the modified physical performance test, which includes seven standardized tasks (walking 50 ft, putting on and removing a coat, picking up a penny, standing up from a chair, lifting a book, climbing one flight of stairs, and performing a progressive Romberg tests) plus two additional tasks (climbing up and down four flights of stairs and performing a 360-degree turn). The score for each task ranges form 0 to 4; a perfect score is 36.
- Change in body weight [18 month]
Measured after an overnight fast using calibrated scales
Secondary Outcome Measures
- Change in body composition (lean mass, fat mass and bone mineral density) [18 month]
Assessed by using dual-energy x-ray absorptiometry
- Volumetric BMD [18 month]
Assessed by using peripheral quantitative computed tomography (pQCT)
- Biochemical Markers of Bone Turnover (Serum C-terminal telopeptide (CTX) [18 month]
measured by ELISA
- Change in prostate specific antigen [18 month]
measured in the blood
- Prostate Symptom Assessment [18 month]
Using the International Prostate Symptom Scoring
- Mood [18 month]
Using the Geriatric Depression Scale
- Quality of Life [18 month]
Using SF-36 and impact of weight on quality of life short form (IWQOL-lite)
- Sexual function [18 month]
Using the International Index of Erectile Function
- Change in trabecular bone score [18 month]
Using DXA
- Change in muscle strength and quality [18 month]
Using biodex dynamometry
- Change in balance [18 month]
as measured by leg stance and obstacle course
- Change in Functional Status [18 month]
Using functional status questionnaire
- Change in gait [18 month]
as measured by completing the time to walk a certain distance
- Change in bone quality [18 month]
Using HrpQCT
- Change in testosterone level [18 month]
as measured in the blood
- Change in sex hormone globulin [18 month]
as measured in the blood
- Change in metabolic hormones [18 month]
Leptin, adiponectin, and similar metabolic hormones as measured in the blood
- Change in Composite cognitive z-score [18 month]
using cognitive instrument testing
- Change in Modified mini-mental exam [18 month]
using cognitive instrument testing
- Change in Stroop color naming [18 month]
using cognitive instrument testing
- Change in Word list fluency [18 month]
using cognitive instrument testing
- Change in Ray auditory verbal learning test [18 month]
using cognitive instrument testing
- Change in Trail A/B [18 month]
using cognitive instrument testing
- Change in waist circumference [18 month]
as measured
- Change in serum PTH [18 month]
as measured in the blood
- Change in lipid profile [18 month]
as measured in the blood
- Change in blood pressure [18 month]
as measured by sphygmomanometry
- Change in metabolic syndrome [18 month]
using harmonized metabolic syndrome criteria
- bone strength index [18 months]
assessed by pQCT
- Cortical to total area [18 months]
assessed by pQCT
- Change in density weighted polar section modulus [18 months]
assessed by pQCT
- Change in cortical density [18 months]
assessed by pQCT
- Change in cortical area [18 months]
assessed by pQCT
- Change in Biochemical Markers of Bone Turnover (PINP) [18 months]
measured by RIA
- Change in lipid profile [18 months]
measured in the blood
- Change in vitamin D level [18 months]
measured in the blood
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Overweight/obese (BMI = or > 27 kg/m2)
-
Older (65-85 yr)
-
Male veteran patients being seen at the PI's endocrine clinic and receiving standard of care consisting of diet and regular exercise counseling
-
Diagnosed with hypogonadism on current or previous testosterone replacement at the PI's endocrine clinic
-
Willing to provide informed consent
Exclusion Criteria:
-
Failure to provide informed consent
-
Unstable cardiopulmonary disease (e.g. recent MI, unstable angina, stroke) or unstable disease (Class III or IV congestive heart failure).
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Michael E DeBakey VA Medical Center | Houston | Texas | United States | 77030 |
Sponsors and Collaborators
- Baylor College of Medicine
Investigators
- Principal Investigator: Dennis T Villareal, MD, Baylor College of Medicine
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- H-40598